Detail akcie AmerisourceBergn online

Business Summary: Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Financial Summary: BRIEF: For the six months ended 31 March 2025, Cencora Inc revenues increased 12% to $156.94B. Net income increased 18% to $1.21B. Revenues reflect Human Health segment increase of 13% to $139.57B, Alliance Healthcare segment increase of 3% to $11.77B, Animal Health segment increase of 6% to $2.74B. Net income benefited from U.S. Healthcare Solutions segment income increase of 17% to $1.8B. Dividend per share increased from $1.02 to $1.10.